
On June 20, 2025, BrainMind hosted an invitation-only Investor Roundtable at the Harvard Club of Boston to explore how ethical considerations can be more intentionally embedded into early-stage investment and governance decisions in neurotechnology. The gathering brought together a select group of values-aligned investors to examine real-world case studies, share insights, and co-develop practical tools for responsible innovation.
As a result of this meeting, two participant-led working groups were launched—one to design a Joint Investor–Founder Agreement and another to build an Ethics & Reputation Risk Matrix. The event catalyzed continued collaboration leading up to Asilomar for the Brain and Mind 2026 and reinforced BrainMind’s mission to shape the trajectory of neurotechnology for long-term societal benefit.
Read the draft meeting report here.
Agenda:
June 19th
6:00-9:30 PM – Pre-Gathering Dinner
June 20th
8:00-9:00 AM – Breakfast
9:00-9:30 AM – Welcome, Context & Connection
9:30-12:15 AM – Hindsight as Foresight
12:15-1:30 PM – Lunch
1:30-2:45 PM – Identifying Opportunities for Influence
2:45-3:45 PM – Sharing & Refining Ideas
3:45-4:30 PM – Next Steps & Closing Conversation